Evidence map›Paper›PMID 41078392›Full record

ReviewFrontiers in chemistry2025

Advances in nucleic acid probe-based detection of gene point mutations: a review.

Xuyang Pu, Xueqiang Wu

Abstract readReview
In one paragraph

Review in Frontiers in chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Xuyang PuAffiliated Meizhou Hospital of Shantou University Medical College, Shantou University, Meizhou, China.
Xueqiang WuAffiliated Meizhou Hospital of Shantou University Medical College, Shantou University, Meizhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A fundamental characteristic of gene mutations is the permanent alteration of the DNA sequence, including point mutations, deletions, inversions, and translocations. Among these, DNA point mutation detection has consistently remained a central focus of research across multiple disciplines due to its close association with a range of diseases, such as sickle cell anemia and β-thalassemia. However, the typically low abundance of such mutations presents a significant technical challenge. Due to technical limitations in detection sensitivity, increasing research efforts have been directed toward nucleic acid probe-based strategies to enhance the efficiency and accuracy of point mutation identification. This review summarizes the developments in nucleic acid probe-based techniques for detecting gene point mutations, with an emphasis on strategies involving pure nucleic acid probes as well as the synergistic use of enzymes, nucleic acid analogs, and nanotechnology. The principles, advantages, and limitations of the above technologies are also described and summarized. In addition, we also explored the application of AI technology in nucleic acid probes and the potential future challenges.

Indexed as

enzymeslow-level mutationmutation detectionnanomaterialsnucleic acid analogspoint mutations

Identifiers

PMID41078392
PMCPMC12507828

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.